Heather Lee Whipple

Senior Vice President, Health Strategies


Heather Lee Whipple

Heather Lee is responsible for leading and expanding the brand market access insights capabilities within Health Strategies Insights, the comprehensive market access research and insights portfolio, in order to help life science innovators make more informed decisions throughout the product lifecycle.

With more than 20 years of experience leading market access strategy and innovation, Heather Lee is an expert on the ongoing evolution of the US healthcare system and its strategic implications for the biopharmaceutical industry. In previous roles, she has led global business transformation strategy and launched a government channel marketing and strategy team.

She holds an MBA with a healthcare marketing concentration from the University of North Carolina at Chapel Hill.


Research & Insights

Articles by Heather Lee Whipple

ICER’s Unsupported Price Increase Assessment

In October 2019, the Institute of Clinical and Economic Review (ICER) released their first annual report on Unsupported Price Increases of prescription drugs in the United States. The report takes a systematic approach to determine whether certain price increases are justified by new clinical evidence or other factors. Our Health Strategies Insights team conducted a […]

Decoding ICER: Successful Pharma Engagement with ICER for U.S. HTA Review

How pharmaceutical and Biotech companies engaged ICER drives the outcome. Reactive responses to ICER review have led to poor outcomes and numerous downstream impacts to payer access and pricing. Cohesive enterprise engagement has demonstrated significantly better recommendations and less pressure for the US payer community. Unfortunately, ‘reactive-response’ is more common than ‘enterprise engagement.’ KEY SUCCESS […]

Interested in scheduling a meeting or speaking event?

Contact Us

  • This field is for validation purposes and should be left unchanged.